Breaking News on Pharmaceutical Technology

News in brief

New Jersey R&D sites vital, says Merck CEO

05-Nov-2009 - US R&D facilities in Rahway and Kenilworth, New Jersey will remain operational as they are vital to the to the newly formed Merck Schering-Plough group, according to CEO Richard Clark.

News in brief

GSK and Pfizer launch ViiV Healthcare

04-Nov-2009 - GSK and Pfizer have launched their HIV focused JV, ViiV Healthcare with the promise that it will undertake “relentless pursuit” of new drugs.

DNA tests required for Trovan claimants after data lost

03-Nov-2009 - Pfizer and Nigerian authorities want Trovan compensation claimants to provide DNA samples to confirm their identity, according to former Nigerian Supreme court justice Abubakar Wali.

People on the move: pharma jobs

03-Nov-2009 - in-PharmaTechnologist presents its latest roundup of movements in the pharma sector, including appointments at Intrexon, Cephalon, NeoPharma and Chelsea Therapeutics.

Influenza: statins may help, but did aspirin misuse hinder in 1918?

02-Nov-2009 - Early-stage CDC research suggests that the anti-inflammatory properties of cholesterol-busting statin drugs can help mitigate the impact of flu infection.

Efficacy at Ph III: lupus drug Benlysta confirms blockbuster potential

02-Nov-2009 - Good news for Human Genome Sciences (HGS) as development partner GSK reports Ph III data showing that their co-owned lupus treatment Benlysta (belimumab) is effective.

Work begins on Indian seasonal flu vacc plant

29-Oct-2009 - Novavax says its new Indian vaccine plant will be operational in four months with sufficient capacity to help meet local demand for seasonal influenza vaccines.

News in brief

Pfizer, GSK and Bayer accept Ecuador’s plan to break patents

29-Oct-2009 - Late last week Ecuador’s government announced plans to sidestep patents on more than 2,000 drugs, enabling them to produced local or imported as “generics”

OctoPlus, Glycotope, Merck KGaA and SCM Pharma on BioPh 2009

29-Oct-2009 - How successful was the BioPh conference in Madrid? in-PharmaTechnologist asked key players attending the inaugural event.

People on the move: pharma jobs

27-Oct-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Hospira, PTI, Migenix and Shrink Nanotechnologies.

IMS Health looking at buyout bids

22-Oct-2009 - IMS Health has confirmed it is “exploring strategic alternatives” after speculation this week suggested that the market analysis group had received a number of takeover bids.

FDA buys fake Tamiflu to warn consumers

21-Oct-2009 - The FDA has warned consumers about the spread of counterfeit H1N1 treatments after the agency bought products advertised as Tamiflu (oseltamivir) that contained none of the active ingredient.

Kimtech cleanroom coveralls launched

21-Oct-2009 - Kimberly-Clark Professional has launched Kimtech Pure A5 cleanroom coveralls, for sterile and non-sterile environments, to provide an affordable way to reduce the risk of contamination.

H Lundbeck eschews outsourcing and buys Elaiapharm

20-Oct-2009 - CNS focused drugmaker H Lundbeck says its acquisition of French CMO Elaiapharm represents a cheaper option than third-party manufacturing.

News in brief

FDA approves Cervarix; also Gardasil for men

20-Oct-2009 - The US Food and Drug Administration (FDA) has approved Cervarix for vaccination against HPV and also granted a new indication to its rival Gardasil, which is now permitted for use in men.

People on the move: pharma jobs

20-Oct-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Peregrine Pharmaceuticals, Seaside Therapeutics and Eucodis.

Write for In-PharmaTechnologist.com

19-Oct-2009 - Do you enjoy reading our latest headlines? Then, why not help to write them yourself by working as a freelance correspondent for In-PharmaTechnologist.com?

ACRO wants trials for most biosimilars

15-Oct-2009 - ACRO says while a 12-year exclusivity period for innovative drugs is important for R&D, US legislation should include rules on trials for biosimilars

News in brief

Lilly sells Tippecanoe API site to Evonik

15-Oct-2009 - US drugmaker Eli Lilly will sell its Tippecanoe laboratories API manufacturing unit to Germany’s Evonik Industries.

Dispatches from CPhI

Gene therapy to drive viral and biologics market, says SAFC

14-Oct-2009 - SAFC Pharma has added extra viral and biologics capacity at its California plant in a $12m project that allows it to take projects from the lab to commercial scale.

Novartis options Heptares’ Star GPCR tech in $200m deal

13-Oct-2009 - Novartis has optioned rights to apply Heptares Therapeutics’ Star GPCR technology to one of its drug development programmes in a deal that, the UK firm says, could be worth over $200m.

People on the move: pharma jobs

13-Oct-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including elections to ISPE's board and a Roche exec joining Dendreon's board.

CPhI 2009 show preview

08-Oct-2009 - We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies.

Court sides with GSK over parallel trade restrictions

08-Oct-2009 - GlaxoSmithKline (GSK) and other pharmas concerned by parallel trade have been given encouragement by Europe’s highest court which said the EC must reconsider the company’s Spanish sale conditions.